Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma

Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 6, 2009, Pages 737-742

  Hillel, Alexander T ^a   Fakhry, Carole ^a   Pai, Sara I ^a   Williams, Mark F ^a,b   Blanco, Ray G F ^a,b   Zinreich, Eva S ^c   Levine, Marshall A ^c   Westra, William H ^a   Saunders, John R ^a,b   Ha, Patrick K ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Milton J Dance Jr Head and Neck Center   (United States)

^c GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CASE STUDY; CHYLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMATOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; POSTOPERATIVE COMPLICATION; RADIATION DOSE; RETROSPECTIVE STUDY; SHOULDER DISEASE; SMOKING; SQUAMOUS CELL CARCINOMA; TEACHING HOSPITAL; TREATMENT RESPONSE; WEAKNESS; WOUND COMPLICATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OROPHARYNGEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70449668965     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.09.010     Document Type: Article

References (22)

1. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
2. Brizel D.M., Prosnitz R.G., Hunter S., et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1418-1423
3. Sewall G.K., Palazzi-Churas K.L., Richards G.M., et al. Planned postradiotherapy neck dissection: rationale and clinical outcomes. Laryngoscope 117 (2007) 121-128
4. Pellitteri P.K., Robbins K.T., and Neuman T. Expanded application of selective neck dissection with regard to nodal status. Head Neck 19 (1997) 260-265
5. Andersen P.E., Warren F., Spiro J., et al. Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg 128 (2002) 1180-1184
6. Chepeha D.B., Hoff P.T., Taylor R.J., et al. Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. Laryngoscope 112 (2002) 434-438
7. Frank D.K., Hu K.S., Culliney B.E., et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 115 (2005) 1015-1020
8. Stenson K.M., Haraf D.J., Pelzer H., et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 126 (2000) 950-956
9. Deschler D.G., and Day T. TNM staging of head and neck cancer/neck dissection classification. 3rd ed. (2008), American Academy of Head and Neck Surgery, Alexandria (VA)
10. Huang C.C., Qiu J.T., Kashima M.L., et al. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol 11 (1998) 971-977
11. Begum S., Gillison M.L., Ansari-Lari M.A., et al. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 9 (2003) 6469-6475
12. Stenson K.M., Huo D., Blair E., et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope 116 (2006) 33-36
13. McHam S.A., Adelstein D.J., Rybicki L.A., et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?. Head Neck 25 (2003) 791-798
14. Lau H., Phan T., Mackinnon J., et al. Absence of planned neck dissection for the n2-n3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 134 (2008) 257-261
15. Liauw S.L., Mancuso A.A., Amdur R.J., et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 24 (2006) 1421-1427
16. Chan A.W., Ancukiewicz M., Carballo N., et al. The role of postradiotherapy neck dissection in supraglottic carcinoma. Int J Radiat Oncol Biol Phys 50 (2001) 367-375
17. Argiris A., Stenson K.M., Brockstein B.E., et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 26 (2004) 447-455
18. Gillison M.L., Koch W.A., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92 (2000) 709-720
19. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100 (2008) 261-269
20. Nichols A.C., Faquin W.C., Westra W.H., et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 140 (2009) 228-234
21. Ukpo O.C., Ptritchett C.V., Lewis J.E., et al. Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients. Ann Otol Rhinol Laryngol 118 (2009) 368-373
22. Sedaghat A.R., Zhang Z., Begum S., et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 119 (2009) 1542-1549